April 21, 2015|
In the midst of a debate about an experimental drug’s early approval, the US Food and Drug Administration requests that full trial results be released.
April 21, 2015|
April 7, 2015|
Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.
February 20, 2015|
The US Food and Drug Administration will allow the personal genomics company to resume a disease-risk analysis.
February 6, 2015|
US Food and Drug Administration commissioner Margaret Hamburg is stepping down after six years on the job.
February 1, 2015|
While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.
January 15, 2015|
The Institute of Medicine says results from human clinical trials ought to be made available to independent researchers within 18 months.
December 29, 2014|
Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research
December 25, 2014|
This year in life science was marked by paltry federal funding increases, revelations of sequence contamination, and onerous regulations.
December 9, 2014|
A new agreement in the European Union allows genetically engineered crops to be approved without member-state votes, likely allowing several GMO foods to enter the market.
December 8, 2014|
A draft policy from the US National Institutes of Health suggests that clinical studies performed at multiple sites should be reviewed by a single institutional review board.